181 related articles for article (PubMed ID: 32016477)
1. Methylation‑driven genes PMPCAP1, SOWAHC and ZNF454 as potential prognostic biomarkers in lung squamous cell carcinoma.
Zhu Q; Wang J; Zhang Q; Wang F; Fang L; Song B; Xie C; Liu J
Mol Med Rep; 2020 Mar; 21(3):1285-1295. PubMed ID: 32016477
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
[No Abstract] [Full Text] [Related]
3. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
[TBL] [Abstract][Full Text] [Related]
4. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
[TBL] [Abstract][Full Text] [Related]
5. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
Wang W; Wang S; Chu X; Liu H; Xiang M
J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242
[TBL] [Abstract][Full Text] [Related]
6. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
Wang X; Wang X; Li X; Chang Y
J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674
[TBL] [Abstract][Full Text] [Related]
7. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
Zhang M; Sun L; Ru Y; Zhang S; Miao J; Guo P; Lv J; Guo F; Liu B
Int J Mol Med; 2020 Jul; 46(1):252-264. PubMed ID: 32377703
[TBL] [Abstract][Full Text] [Related]
8. Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer.
Fan Y; Gao Z; Li X; Wei S; Yuan K
Bioengineered; 2021 Dec; 12(1):6210-6228. PubMed ID: 34486486
[TBL] [Abstract][Full Text] [Related]
9. Role of downregulated ADARB1 in lung squamous cell carcinoma.
Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
[TBL] [Abstract][Full Text] [Related]
10. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
[TBL] [Abstract][Full Text] [Related]
12. Monitoring methylation-driven genes as prognostic biomarkers in patients with lung squamous cell cancer.
Han P; Liu Q; Xiang J
Oncol Lett; 2020 Jan; 19(1):707-716. PubMed ID: 31897186
[TBL] [Abstract][Full Text] [Related]
13. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
[TBL] [Abstract][Full Text] [Related]
15. Telomere-associated genes and telomeric lncRNAs are biomarker candidates in lung squamous cell carcinoma (LUSC).
Storti CB; de Oliveira RA; de Carvalho M; Hasimoto EN; Cataneo DC; Cataneo AJM; De Faveri J; Vasconcelos EJR; Dos Reis PP; Cano MIN
Exp Mol Pathol; 2020 Feb; 112():104354. PubMed ID: 31837325
[TBL] [Abstract][Full Text] [Related]
16. Identification of miRNA signature for predicting the prognostic biomarker of squamous cell lung carcinoma.
Liu H; Li T; Dong C; Lyu J
PLoS One; 2022; 17(3):e0264645. PubMed ID: 35290415
[TBL] [Abstract][Full Text] [Related]
17. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
Yang K; Wu Y
BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
[TBL] [Abstract][Full Text] [Related]
18. Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Xiong Y; Feng Y; Qiao T; Han Y
Cancer Biomark; 2020; 27(2):243-250. PubMed ID: 32083573
[TBL] [Abstract][Full Text] [Related]
19. Minichromosome maintenance gene family: potential therapeutic targets and prognostic biomarkers for lung squamous cell carcinoma.
Yang X; Wang C; Nie H; Zhou J; He X; Ou C
Aging (Albany NY); 2022 Nov; 14(22):9167-9185. PubMed ID: 36445337
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of
Wang HL; Li KZ; Li JL; Hu BL
Biomark Med; 2020 May; 14(7):503-512. PubMed ID: 32208871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
